LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
26 funds hold it · Insiders net selling
Net selling: insiders sold $14.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 28, 2026
Period ending
Sep 30, 2026
Earnings per share
-$0.12 expected
Estimates as of Nov 10, 2026
EPS expected
$0.07 to $0.66
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 28, 2026 | $0.47est. -$0.12 | +$0.59beat | $211.0MSEC filing | +58.0%from $133.5M |
| Jun 30, 2026Reported Jul 29, 2026 | -$0.14est. -$0.28 | +50.00%beat | $185.6MSEC filing | +49.5%from $124.1M |
| Mar 31, 2026Reported Apr 29, 2026 | -$0.18est. -$0.28 | +35.71%beat | $150.6MSEC filing | +41.2%from $106.7M |
| Dec 31, 2025Reported Feb 17, 2026 | -$0.90est. -$0.21 | -$0.69miss | $143.1MAlpha Vantage | +35.7%from $105.5M |
| Sep 30, 2025Reported Oct 29, 2025 | -$0.16est. -$0.26 | +38.46%beat | $133.5MSEC filing | +38.1%from $96.7M |
| Jun 30, 2025Reported Jul 30, 2025 | -$0.24est. -$0.26 | +7.69%beat | $124.1MSEC filing | +29.7%from $95.7M |
| Mar 31, 2025Reported Apr 30, 2025 | -$0.22est. -$0.35 | +37.14%beat | $106.7MSEC filing | +24.6%from $85.6M |
| Dec 31, 2024Reported Feb 20, 2025 | -$0.40est. -$0.39 | -2.96%miss | $105.5MAlpha Vantage | +28.1%from $82.4M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $143.1M | $150.6M | $185.6M | $211.0M |
| Cost of what it sold | $31.8M | $33.3M | $34.0M | $31.2M |
| Gross profit | $111.3M | $117.2M | $151.6M | $179.9M |
| What it spent | ||||
| Research and development | $43.7M | $44.1M | $51.3M | $48.1M |
| Sales and admin | $94.7M | $92.9M | $116.1M | $75.7M |
| Other operating costs | — | — | — | $55.2M |
| Total operating expenses | $138.4M | $137.1M | $168.9M | $179.0M |
| What was left | ||||
| Operating profit | -$27.0M | -$19.9M | -$17.3M | $828.0K |
| Interest on debt | $1.1M | $1.1M | $1.5M | $1.1M |
| Profit before tax | -$139.8M | -$19.3M | -$17.7M | $2.3M |
| Tax | -$6.2M | $484.0K | $656.0K | $303.0K |
| Net profit | -$133.7M | -$19.8M | -$18.4M | $2.0M |
| EBITDA | -$125.4M | -$5.3M | -$5.6M | $12.4M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
Form 144 GLAUKOS Corp For: 13 November By Investing.com
NeutralNov 13Form 144 GLAUKOS Corp For: 13 November By Investing.com
NeutralNov 13(GKOS) Movement as an Input in Quant Signal Sets
NeutralNov 11GKOS: Epioxa access is advancing; market expansion and payer execution will shape 2027 growth
BullishNov 10Glaukos (GKOS) Jumped, What Is Behind The Fresh Attention?
Leans bearishNov 9Learn Why The Bull Case For Glaukos Stock Could Change Following S&P 400 Inclusion
Leans bullishNov 7Glaukos Shares November 2026 Investor Presentation, Citing 30% 2025 Growth
BullishNov 7Glaukos Corporation (GKOS) Seasonal Returns Chart
NeutralNov 633 macro signals shaping GKOS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
